Circulating MicroRNAs as Biomarkers of Accelerated Sarcopenia in Chronic Heart Failure
References
- von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: Facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle. 2010; 1(2): 129–33. DOI: 10.1007/s13539-010-0014-2
- Morley JE. Sarcopenia: Diagnosis and treatment. J Nutr Health Aging. 2008; 12(7): 452–6. Epub 11 July 2008. DOI: 10.1007/BF02982705
- Collamati A, Marzetti E, Calvani R, et al. Sarcopenia in heart failure: Mechanisms and therapeutic strategies. J Geriatr Cardiol. 2016; 13(7): 615–24. Epub 09 September 2016.
- Fulster S, Tacke M, Sandek A, et al. Muscle wasting in patients with chronic heart failure: Results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur Heart J. 2013; 34(7): 512–9. Epub 28 November 2012. DOI: 10.1093/eurheartj/ehs381
- Kim JY, Park YK, Lee KP, et al. Genome-wide profiling of the microRNA-mRNA regulatory network in skeletal muscle with aging. Aging (Albany NY). 2014; 6(7): 524–44. DOI: 10.18632/aging.100677
- Jung HJ, Lee KP, Milholland B, et al. Comprehensive miRNA Profiling of Skeletal Muscle and Serum in Induced and Normal Mouse Muscle Atrophy During Aging. J Gerontol A Biol Sci Med Sci. 2017; 72(11): 1483–91. DOI: 10.1093/gerona/glx025
- Huang YM, Li WW, Wu J, Han M, Li BH. The diagnostic value of circulating microRNAs in heart failure. Exp Ther Med. 2019; 17(3): 1985–2003. Epub 21 February 2019. DOI: 10.3892/etm.2019.7177
- He N, Zhang YL, Zhang Y, et al. Circulating MicroRNAs in Plasma Decrease in Response to Sarcopenia in the Elderly. Front Genet. 2020; 11: 167. DOI: 10.3389/fgene.2020.00167
- Yanai K, Kaneko S, Ishii H, et al. MicroRNAs in Sarcopenia: A Systematic Review. Front Med (Lausanne). 2020; 7: 180. Epub 18 June 2020. DOI: 10.3389/fmed.2020.00180
- Steinbeck L, Ebner N, Valentova M, et al. Detection of muscle wasting in patients with chronic heart failure using C-terminal agrin fragment: Results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). Eur J Heart Fail. 2015; 17(12): 1283–93. DOI: 10.1002/ejhf.400
- World Medical Association. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 2013; 310(20): 2191–4. DOI: 10.1001/jama.2013.281053
- Qaisar R, Karim A, Muhammad T. Circulating Biomarkers of Handgrip Strength and Lung Function in Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2020; 15: 311–21. DOI: 10.2147/COPD.S225765
- Qaisar R, Karim A, Muhammad T. Plasma CAF22 Levels as a Useful Predictor of Muscle Health in Patients with Chronic Obstructive Pulmonary Disease. Biology (Basel). 2020; 9(7). DOI: 10.3390/biology9070166
- Qaisar R, Qayum M, Muhammad T. Reduced sarcoplasmic reticulum Ca(2+) ATPase activity underlies skeletal muscle wasting in asthma. Life Sci. 2021; 273:
119296 . Epub 07 March 2021. DOI: 10.1016/j.lfs.2021.119296 - Landi F, Russo A, Cesari M, Pahor M, Bernabei R, Onder G. HDL-cholesterol and physical performance: Results from the ageing and longevity study in the sirente geographic area (ilSIRENTE Study). Age Ageing. 2007; 36(5): 514–20. DOI: 10.1093/ageing/afm105
- Qaisar R, Karim A, Muhammad T, Shah I. Circulating Biomarkers of Accelerated Sarcopenia in Respiratory Diseases. Biology (Basel). 2020; 9(10). DOI: 10.3390/biology9100322
- Qaisar R, Pharaoh G, Bhaskaran S, et al. Restoration of Sarcoplasmic Reticulum Ca(2+) ATPase (SERCA) Activity Prevents Age-Related Muscle Atrophy and Weakness in Mice. Int J Mol Sci. 2020; 22(1). Epub 31 December 2020. DOI: 10.3390/ijms22010037
- Alamdari N, Toraldo G, Aversa Z, et al. Loss of muscle strength during sepsis is in part regulated by glucocorticoids and is associated with reduced muscle fiber stiffness. Am J Physiol Regul Integr Comp Physiol. 2012; 303(10): R1090–9. Epub 29 September 2012. DOI: 10.1152/ajpregu.00636.2011
- Franzon K, Zethelius B, Cederholm T, Kilander L. The impact of muscle function, muscle mass and sarcopenia on independent ageing in very old Swedish men. BMC Geriatr. 2019; 19(1): 153. DOI: 10.1186/s12877-019-1142-y
- Vassalle C, Botto N, Andreassi MG, Berti S, Biagini A. Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease. Coron Artery Dis. 2003; 14(3): 213–8. DOI: 10.1097/01.mca.0000063504.13456.c3
- Yin J, Lu X, Qian Z, Xu W, Zhou X. New insights into the pathogenesis and treatment of sarcopenia in chronic heart failure. Theranostics. 2019; 9(14): 4019–29. DOI: 10.7150/thno.33000
- Qaisar R, Karim A, Muhammad T, Shah I, Khan J. Prediction of sarcopenia using a battery of circulating biomarkers. Sci Rep. 2021; 11(1): 8632. Epub 23 April 2021. DOI: 10.1038/s41598-021-87974-6
- Chen JF, Mandel EM, Thomson JM, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet. 2006; 38(2): 228–33. Epub 29 December 2005. DOI: 10.1038/ng1725
- Song T, Manoharan P, Millay DP, et al. Dilated cardiomyopathy-mediated heart failure induces a unique skeletal muscle myopathy with inflammation. Skelet Muscle. 2019; 9(1): 4. DOI: 10.1186/s13395-019-0189-y
- Van Iterson EH, Olson TP. Therapeutic Targets for the Multi-system Pathophysiology of Heart Failure: Exercise Training. Curr Treat Options Cardiovasc Med. 2017; 19(11): 87. DOI: 10.1007/s11936-017-0585-8
- Ooi JYY, Bernardo BC, Singla S, Patterson NL, Lin RCY, McMullen JR. Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases. RNA Biol. 2017; 14(5): 500–13. DOI: 10.1080/15476286.2016.1181251
- Pardo PS, Hajira A, Boriek AM, Mohamed JS. MicroRNA-434-3p regulates age-related apoptosis through eIF5A1 in the skeletal muscle. Aging (Albany NY). 2017; 9(3): 1012–29. Epub 24 March 2017. DOI: 10.18632/aging.101207
- Doss JF, Corcoran DL, Jima DD, Telen MJ, Dave SS, Chi JT. A comprehensive joint analysis of the long and short RNA transcriptomes of human erythrocytes. BMC Genomics. 2015; 16: 952. Epub 18 November 2015. DOI: 10.1186/s12864-015-2156-2
- Cui C, Yang W, Shi J, Zhou Y, Yang J, Cui Q. Identification and Analysis of Human Sex-biased MicroRNAs. Genomics Proteomics Bioinformatics. 2018; 16(3): 200–11. Epub 15 July 2018. DOI: 10.1016/j.gpb.2018.03.004
- Dai A, Sun H, Fang T, et al. MicroRNA-133b stimulates ovarian estradiol synthesis by targeting Foxl2. FEBS Lett. 2013; 587(15): 2474–82. Epub 03 July 2013. DOI: 10.1016/j.febslet.2013.06.023
- Harris-Love MO, Benson K, Leasure E, Adams B, McIntosh V. The Influence of Upper and Lower Extremity Strength on Performance-Based Sarcopenia Assessment Tests. J Funct Morphol Kinesiol. 2018; 3(4). Epub 12 December 2018. DOI: 10.3390/jfmk3040053
DOI: https://doi.org/10.5334/gh.943 | Journal eISSN: 2211-8179
Language: English
Submitted on: Oct 27, 2020
Accepted on: May 30, 2021
Published on: Aug 30, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2021 Rizwan Qaisar, Asima Karim, Tahir Muhammad, Islam Shah, Javaidullah Khan, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.